Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Sep;70(9):1519-1529.
doi: 10.1002/art.40519. Epub 2018 Jul 22.

Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition

Affiliations
Comparative Study

Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition

Stephanie J W Shoop-Worrall et al. Arthritis Rheumatol. 2018 Sep.

Abstract

Objective: Potential targets for treat-to-target strategies in juvenile idiopathic arthritis are minimal disease activity (MDA) and clinically inactive disease (CID). We undertook this study to compare short- and long-term outcomes following achievement of MDA and CID on the 10-joint clinical Juvenile Arthritis Disease Activity Score (cJADAS10) and following achievement of CID on Wallace et al's preliminary criteria.

Methods: Children recruited to the Childhood Arthritis Prospective Study, a UK multicenter inception cohort, were selected if they were recruited prior to January 2011 and diagnosed as having oligoarthritis or rheumatoid factor-negative or -positive polyarthritis. One year following diagnosis, children were assessed for MDA on the cJADAS10 and for CID on both Wallace et al's preliminary criteria and the cJADAS10. Associations were tested between those disease states and functional ability, absence of joints with limited range of motion, psychosocial health, and pain at 1 year and annually to 5 years.

Results: Of 832 children, 70% were female and the majority had oligoarthritis (68%). At 1 year, 21% had achieved CID according to both definitions, 7% according to Wallace et al's preliminary criteria alone, and 16% according to the cJADAS10 alone; 56% had not achieved CID. Only 10% of children in the entire cohort achieved MDA without also achieving CID. Achieving either early CID state was associated with a greater absence of joints with limited range of motion. However, only CID according to the cJADAS10 was associated with improved functional ability and psychosocial health. Achieving CID was superior to achieving MDA in terms of short- and long-term pain and the absence of joints with limited range of motion.

Conclusion: CID on the cJADAS10 may be preferable as a treatment target to CID on Wallace et al's preliminary criteria in terms of both feasibility of application and long-term outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Outcomes over 5 years following initial presentation to a pediatric rheumatology clinic, split according to clinically inactive disease (CID) state at 1 year. A, Median Childhood Health Assessment Questionnaire (C‐HAQ) scores. Median C‐HAQ scores over the 5 years were the same whether CID was measured according to both Wallace et al’s preliminary criteria and the 10‐joint clinical Juvenile Arthritis Disease Activity Score (cJADAS10) or according to the cJADAS10 alone. B, Percentages of subjects having no joints with limited range of motion. C, Median Child Health Questionnaire (CHQ) psychosocial scores.
Figure 2
Figure 2
Outcomes over 5 years following initial presentation to a pediatric rheumatology clinic, split according to clinically active disease, clinically inactive disease (CID), and minimal disease activity (MDA) on the 10‐joint clinical Juvenile Arthritis Disease Activity Score (cJADAS10). A, Median Childhood Health Assessment Questionnaire (C‐HAQ) scores. B, Percentages of subjects having no joints with limited range of motion. C, Median Child Health Questionnaire (CHQ) psychosocial scores. D, Median pain scores.

References

    1. National Institute for Health and Care Excellence . Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis. 2002. URL: https://www.nice.org.uk/guidance/ta35.
    1. Davies K, Cleary G, Foster H, Hutchinson E, Baildam E. BSPAR standards of care for children and young people with juvenile idiopathic arthritis. Rheumatology (Oxford) 2010;49:1406–8. - PubMed
    1. Shoop‐Worrall SJ, Kearsley‐Fleet L, Thomson W, Verstappen SM, Hyrich KL. How common is remission in juvenile idiopathic arthritis: a systematic review. Semin Arthritis Rheum 2017;47:331–7. - PMC - PubMed
    1. Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016;75:3–15. - PMC - PubMed
    1. Stoffer MA, Schoels MM, Smolen JS, Aletaha D, Breedveld FC, Burmester G, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann Rheum Dis 2016;75:16–22. - PMC - PubMed

Publication types

Substances